Update on the Phase 4 ENVISION Confirmatory Study of ADUHELM®
Go back to Update on the Phase 4 ENVISION Confirmatory Study of ADUHELM®| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 205.70 -2.76 (1.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $208.46 | 52 Week High | $333.65 | |||
| Open | $211.86 | 52 Week Low | $223.02 | |||
| Day High | $212.00 | P/E | 26.34 | |||
| Day Low | $205.65 | EPS | $7.81 | |||
| Volume | 1,156,882 | |||||

